A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression

Completed · Phase 2

Conditions studied: Depression

In brief

The purpose of this study is to determine whether a combination of naltrexone SR and bupropion SR is safe and effective in the treatment of major depression in overweight or obese subjects.

Key facts

Study ID
NCT00624858
Run by
Orexigen Therapeutics, Inc
People needed
25
Starts
2008-01-01
Expected to finish
2009-07-01
Last updated by the study team
2012-10-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.